Evening aspirin intake results in higher levels of platelet inhibition and a reduction in reticulated platelets - a window of opportunity for patients with cardiovascular disease?
Cardiovascular events occur most frequently in the early morning. Similarly, the release of reticulated platelets (RP) by megakaryocytes has a peak in the late night and early morning. Which aspirin regimen most effectively inhibits platelets during these critical hours is unknown. Hence, the primar...
Main Authors: | J.J.K. van Diemen, M.C. Madsen, P. Vrancken, K. de Bie, J.G. van der Bom, G. Veen, T.N. Bonten, W.W. Fuijkschot, Y.M. Smulders, A. Thijs |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-08-01
|
Series: | Platelets |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09537104.2020.1809643 |
Similar Items
-
Aspirin intake in the morning is associated with suboptimal platelet inhibition, as measured by serum Thromboxane B2, during infarct-prone early-morning hours
by: Cati Racca, et al.
Published: (2019-10-01) -
Circadian Rhythm of Cardiovascular Disease: The Potential of Chronotherapy With Aspirin
by: Marleen Buurma, et al.
Published: (2019-06-01) -
Artificial intelligence, platelets and aspirin
by: Giovanni de Gaetano
Published: (2024-03-01) -
Influence of Sex on Platelet Reactivity in Response to Aspirin
by: Kevin A. Friede, et al.
Published: (2020-07-01) -
Blood platelets, prostaglandins and aspirin: a historical and personal rereading
by: Giovanni de Gaetano, et al.
Published: (2024-03-01)